GLP-1RA Semaglutide(Tirz, Reta) reduces depression and anxiety in users
Since FDA approved Semaglutide for the treatment of obesity, GLP-1RA has occupied the majority of the market for the treatment of obesity. As more and more people use GLP-1RA, including Semaglutide, they found it in addition to helping with weight loss and adjusting the body’s metabolic level, GLP-1RA also affects the user’s mental health, including reducing anxiety and controlling a …
My weight loss peptide Retatrutide does not work, what to do?
As one of the latest weight loss peptides, Retatrutide’s triple receptor activation has attracted the attention of many Semaglutide users and Tirzpatide users. At the same time, like Semaglutide, it acts on GLP-1 receptors, and like Tirzpatide, it acts on GLP-1 receptors and GIP receptors. As a result, users tend to experience fewer side effects when they switch to Retatrutide, …
